The Corporate Venturing in Life Sciences Conference will provide corporate venturing and commercialization professionals with a unique opportunity to join their peers in the pharmaceutical, biotechnology, and medical device industries to discuss issues central to enhancing their venturing, licensing, and innovation practices.
Corporate Venturing in the Life Sciences Conference
November 13-14, 2013
Boston, MA
The Corporate Venturing in Life Sciences Conference will provide corporate venturing and commercialization professionals with a unique opportunity to join their peers in the pharmaceutical, biotechnology, and medical device industries to discuss issues central to enhancing their venturing, licensing, and innovation practices.
Join leading corporate venturing experts from Merck, Pfizer, Abbvie, Covidien, Medtronic, Boehring Ingelheim, and many others!
Benefits of marcus evans Conferences:
– Peer-to-peer driven meeting specifically focused on implementing venturing models to build enhanced partnerships
– Intimate classroom style setting that encourages audience engagement and participation
– 15+ highly interactive case studies and panel discussions
– 10-15 minutes of Q&A time following each session
– 4+ hours of networking opportunities with leading corporate venturing and commercialization professionals in the life sciences
– Exclusive access to speaker presentations post-event for you to reference back at the office
For more information, please visit http://www.marcusevansch.com/CVLS2013_GCV
For registration and pricing information, please e-mail Robin Yegelwel at robiny@marcusevansch.com or call (312) 540-3000 ext. 6483
Please note: Seats are limited to 50 delegates and are on a first-come, first-serve basis. Inquire today to ensure availability!
